Blueberries Medical (BBRRF) has a profit margin of -383.57%, below the sector sector average of 13.16%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for BBRRF is -383.57% as of June 2026. That compares with -350.71% in the prior-year period — down 9.4% year over year. That is below the sector sector average of 13.16%. Investors often review this figure alongside Blueberries Medical's historical trend and sector peers before judging valuation or financial health.
Over the past year, BBRRF's profit margin moved from -350.71% to -383.57% — a 9.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Blueberries Medical's valuation or profitability profile.
Against its sector companies, BBRRF currently prints -383.57% for profit margin, while the sector average sits near 13.16%. That is roughly 3013.9% below the sector mean. Large gaps often invite a closer look at Blueberries Medical's growth, margins, and balance sheet.
Profit Margin shows how effectively Blueberries Medical converts resources into returns. At -383.57%, BBRRF may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -350.71% in the prior-year period — down 9.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting BBRRF's profit margin (-383.57%), review year-over-year change from -350.71%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.